zolvix plus broad spectrum oral anthelmintic for sheep
elanco australasia pty ltd - abamectin; ahc-2102225 (monepantel) - oral solution/suspension - abamectin anthelmintic active 2.0 mg/ml; ahc-2102225 (monepantel) anthelmintic active 25.0 mg/ml - parasiticides
coopers paramax-f broad spectrum oral anthelmintic and flukicide for sheep
intervet australia pty limited - ivermectin; triclabendazole - oral solution/suspension - ivermectin anthelmintic active 1.0 g/l; triclabendazole triazole active 50.0 g/l - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | cooperia curticei | cooperia oncophora | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large lungworm - dictyocaulus filaria | large mouthed bowel worm | large stomach worm | liver fluke | nasal bot - parasitic larval stage | nematodirus filicollis | nodule worm - o. columbianum | ostertagia circumcincta | sheep itch mite | stomach hair worm | thin necked intestinal worm-n. spathiger | whipworm - trichuris ovis | barber's pole worm | psorobia ovis | sheep nasal bot fly | small brown stomach worm | small intestinal worm | thin necked intestinal worm | thin necked intestinal worm-ad | trichostrongylus colubriformis | trichostrongylus vitrinus
erwinaze- asparaginase injection, powder, lyophilized, for solution
jazz pharmaceuticals, inc. - asparaginase erwinia chrysanthemi (unii: d733et3f9o) (asparaginase - unii:g4fq3cky5r) - asparaginase 10000 [iu] in 1 ml - erwinaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (all) who have developed hypersensitivity to e. coli -derived asparaginase. erwinaze is contraindicated in patients with a history of: risk summary based on findings from animal reproduction studies, erwinaze can cause fetal harm when administered to a pregnant woman. in animal reproduction studies, intramuscular administration of asparaginase erwinia chrysanthemi to pregnant rats and rabbits during organogenesis at doses approximately 0.005-0.5 times the maximum recommended human dose resulted in structural abnormalities and embryo-fetal mortality (see data). there are no available data on erwinaze use in pregnant women to evaluate the drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. advise pregnant women of the potential risk to the fetus. the estimated background risk of major birth defects and miscarriage for the ind
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -
amanita pantherina pellet
hahnemann laboratories, inc. - amanita pantherina fruiting body (unii: 4wr9dan53i) (amanita pantherina fruiting body - unii:4wr9dan53i) -